Midatech Pharma PLC. Daily Stock Analysis

Daily Stock Analysis, MTP, Midatech Pharma PLC, priceseries

Midatech Pharma PLC. Daily Stock Analysis
Stock Information
Open
0.84
Close
0.86
High
0.87
Low
0.83
Previous Close
0.90
Daily Price Gain
-0.04
YTD High
1.33
YTD High Date
Jan 6, 2022
YTD Low
0.82
YTD Low Date
Feb 24, 2022
YTD Price Change
-0.28
YTD Gain
-24.61%
52 Week High
3.61
52 Week High Date
Jun 17, 2021
52 Week Low
0.82
52 Week Low Date
Feb 24, 2022
52 Week Price Change
-1.07
52 Week Gain
-55.47%
Recent priceSeries Trade Signals

These are sample algorithmic trades based on actual market data.

Trade Type
Entry Date
Entry Price
Exit Date
Exit Price
Trade Hold Time
Gain
Trade Record
LONG
Jun 6. 2017
136.46
Jun 7. 2017
146.56
1 Trading Days
7.40%
Link
LONG
Nov 21. 2017
69.50
Nov 24. 2017
74.50
2 Trading Days
7.19%
Link
LONG
May 1. 2018
44.80
May 3. 2018
49.65
2 Trading Days
10.83%
Link
LONG
Aug 29. 2018
31.29
Sep 10. 2018
33.62
7 Trading Days
7.45%
Link
LONG
Nov 1. 2018
24.50
Nov 2. 2018
27.00
1 Trading Days
10.22%
Link
LONG
Mar 30. 2020
1.98
Mar 31. 2020
2.08
1 Trading Days
5.16%
Link
LONG
Apr 27. 2020
1.73
May 13. 2020
2.90
12 Trading Days
66.93%
Link
LONG
Jul 17. 2020
1.55
Jul 28. 2020
2.06
7 Trading Days
33.04%
Link
LONG
Jan 13. 2021
2.10
Jan 26. 2021
2.23
8 Trading Days
6.13%
Link
LONG
Feb 3. 2021
2.58
Feb 11. 2021
2.86
6 Trading Days
10.83%
Link
Company Information
Stock Symbol
MTP
Exchange
NasdaqCM
Company URL
http://http://midatechgroup.com
Company Phone
44 (0)1235 888 300
CEO
N/A
Headquarters
-
Business Address
65 INNOVATION DRIVE, MILTON PARK, ABINGDON, OXFORDSHIRE, UNITED KINGDOM OX14 4RQ
Sector
Equity
Industry Category
-
Industry Group
-
CIK
0001643918
About

Midatech Pharma PLC, a specialty pharmaceutical company, focuses on the development and commercialization of target therapies for various diseases with unmet needs.

Description

Midatech Pharma PLC, a specialty pharmaceutical company, focuses on the development and commercialization of target therapies for various diseases with unmet needs. It offers Zuplenz, an oral soluble film for chemotherapy-induced nausea and vomiting, radiotherapy-induced nausea and vomiting, and post-operative nausea and vomiting; Gelclair, an oral rinse gel, for the management and relief of pain due to oral mucositis; Oravig, an orally dissolving buccal tablet for oral thrush; and Soltamox, an oral liquid solution of tamoxifen citrate, for the prevention of breast cancer. The company is also developing a pipeline of clinical and preclinical product candidates focused on therapeutic areas of cancer; endocrine disorders, such as diabetes; and immunotherapy for autoimmune diseases. The company was founded in 2000 and is based in Abingdon, the United Kingdom.

TCHANNELS® is a Registered Trademark with USPTO

Some images used on this site have been taken from Unsplash

Legal Information

Useful Links

Contact Us

PO Box 2574, Sunnyvale
California 94087-0574, USA
Phone: 408-940-5056
Email: Click to send us an Email

Risks of Algorithmic Trading: Before investing please read our disclosure on Risks of Algorithmic Trading.

DISCLAIMER All investments entail inherent risk. This research seeks to assist investors in determining when to buy and when to sell to attempt to maximize profits or minimize losses. All final investment decisions are yours and as a result you could make or lose money. priceSeries.com, its employees and/or its affiliates and family members may from time to time take positions in the open market or otherwise with respect to the securities discussed. priceSeries.com, its employees and/or affiliates do not have stock ownership equal to or greater than 1% of the outstanding stock of the covered company nor does any employee of priceSeries.com sit on the Board of Directors of any covered company. priceSeries.com is not a broker/dealer, and the firm does not underwrite securities, manage assets or perform investment banking activities. The statements made herein include information obtained from sources believed to be reliable, but no independent verification has been made and we do not guarantee its accuracy or completeness.

U.S. Government Required Disclaimer - Commodity Futures Trading Commission
Futures and Options trading has large potential rewards, but also large potential risk. You must be aware of the risks and be willing to accept them in order to invest in the futures and options markets. Don't trade with money you can't afford to lose. This is neither a solicitation nor an offer to Buy/Sell futures or options. No representation is being made that any account will or is likely to achieve profits or losses similar to those discussed on this web site. The past performance of any trading system or methodology is not necessarily indicative of future results.

CFTC RULE 4.41 - HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING. ALSO, SINCE THE TRADES HAVE NOT BEEN EXECUTED, THE RESULTS MAY HAVE UNDER-OR-OVER COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFIT OR LOSSES SIMILAR TO THOSE SHOWN.

2016 © priceSeries.com All Rights Reserved. Privacy Policy | Subscriber Agreement | Risks of Algorithmic Trading